Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Jul;91(3):475–479. doi: 10.1111/j.1476-5381.1987.tb11239.x

Failure of the calcium channel activator, Bay K 8644, to increase the release of acetylcholine from nerve terminals in brain and diaphragm.

V Dolezal, S Tucek
PMCID: PMC1853538  PMID: 2440507

Abstract

The calcium channel activator Bay K 8644 did not increase the release of acetylcholine from rat brain cortex prisms incubated in the presence of 3 mmol l-1 or 25 mmol l-1 K+ nor from rat diaphragms incubated in the presence of 5 mmol l-1 or 25 mmol l-1 K+. It also did not influence the release of acetylcholine from cortex prisms incubated in the presence of 25 mmol l-1 K+ and of lowered concentrations of Ca2+ ions. It is concluded that the voltage-dependent Ca2+ channels in the nerve terminals, responsible for the depolarization-induced influx of Ca2+ ions into the nerve terminals and thus for the depolarization-evoked release of acetylcholine from the nerve terminals, are different from the voltage-dependent Ca2+ channels in the heart and smooth muscle cells.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam-Vizi V., Ligeti E. Calcium uptake of rat brain synaptosomes as a function of membrane potential under different depolarizing conditions. J Physiol. 1986 Mar;372:363–377. doi: 10.1113/jphysiol.1986.sp016013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albus U., Habermann E., Ferry D. R., Glossmann H. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells. J Neurochem. 1984 Apr;42(4):1186–1189. doi: 10.1111/j.1471-4159.1984.tb12729.x. [DOI] [PubMed] [Google Scholar]
  3. Artalejo C. R., Garcia A. G. Effects of Bay K 8644 on cat adrenal catecholamine secretory responses to A23187 or ouabain. Br J Pharmacol. 1986 Aug;88(4):757–765. doi: 10.1111/j.1476-5381.1986.tb16248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carvalho C. A., Coutinho O. P., Carvalho A. P. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes. J Neurochem. 1986 Dec;47(6):1774–1784. doi: 10.1111/j.1471-4159.1986.tb13088.x. [DOI] [PubMed] [Google Scholar]
  5. Ceña V., García A. G., Khoyi M. A., Salaices M., Sanchez-García P. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens. Br J Pharmacol. 1985 Jul;85(3):691–696. doi: 10.1111/j.1476-5381.1985.tb10565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daniell L. C., Barr E. M., Leslie S. W. 45Ca2+ uptake into rat whole brain synaptosomes unaltered by dihydropyridine calcium antagonists. J Neurochem. 1983 Nov;41(5):1455–1459. doi: 10.1111/j.1471-4159.1983.tb00845.x. [DOI] [PubMed] [Google Scholar]
  7. Dolezal V., Tucek S. The effects of 4-aminopyridine and tetrodotoxin on the release of acetylcholine from rat striatal slices. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(2):90–95. doi: 10.1007/BF00634254. [DOI] [PubMed] [Google Scholar]
  8. Dolezal V., Tucek S. The synthesis and release of acetylcholine in normal and denervated rat diaphragms during incubation in vitro. J Physiol. 1983 Jan;334:461–474. doi: 10.1113/jphysiol.1983.sp014506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Finet M., Godfraind T., Khoury G. The positive inotropic action of the nifedipine analogue, Bay K 8644, in guinea-pig and rat isolated cardiac preparations. Br J Pharmacol. 1985 Sep;86(1):27–32. doi: 10.1111/j.1476-5381.1985.tb09431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fleckenstein A. Calcium antagonism in heart and vascular smooth muscle. Med Res Rev. 1985 Oct-Dec;5(4):395–425. doi: 10.1002/med.2610050402. [DOI] [PubMed] [Google Scholar]
  11. Goldberg A. M., McCaman R. E. The determination of picomole amounts of acetylcholine in mammalian brain. J Neurochem. 1973 Jan;20(1):1–8. doi: 10.1111/j.1471-4159.1973.tb12097.x. [DOI] [PubMed] [Google Scholar]
  12. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  13. Kanmura Y., Itoh T., Kuriyama H. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery. J Pharmacol Exp Ther. 1984 Dec;231(3):717–723. [PubMed] [Google Scholar]
  14. Kendall D. A., Nahorski S. R. Dihydropyridine calcium channel activators and antagonists influence depolarization-evoked inositol phospholipid hydrolysis in brain. Eur J Pharmacol. 1985 Sep 10;115(1):31–36. doi: 10.1016/0014-2999(85)90580-1. [DOI] [PubMed] [Google Scholar]
  15. Kokubun S., Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4824–4827. doi: 10.1073/pnas.81.15.4824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Middlemiss D. N., Spedding M. A functional correlate for the dihydropyridine binding site in rat brain. Nature. 1985 Mar 7;314(6006):94–96. doi: 10.1038/314094a0. [DOI] [PubMed] [Google Scholar]
  17. Middlemiss D. N. The calcium channel activator, Bay K 8644, enhances K+-evoked efflux of acetylcholine and noradrenaline from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):114–116. doi: 10.1007/BF00498860. [DOI] [PubMed] [Google Scholar]
  18. Nowycky M. C., Fox A. P., Tsien R. W. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2178–2182. doi: 10.1073/pnas.82.7.2178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Perney T. M., Hirning L. D., Leeman S. E., Miller R. J. Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6656–6659. doi: 10.1073/pnas.83.17.6656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977 Dec;83(2):346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
  21. Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annu Rev Biochem. 1983;52:871–926. doi: 10.1146/annurev.bi.52.070183.004255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Reuter H., Kokubun S., Prod'hom B. Properties and modulation of cardiac calcium channels. J Exp Biol. 1986 Sep;124:191–201. doi: 10.1242/jeb.124.1.191. [DOI] [PubMed] [Google Scholar]
  23. Rogg H., Criscione L., Truog A., Meier M. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644. J Cardiovasc Pharmacol. 1985;7 (Suppl 6):S31–S37. doi: 10.1097/00005344-198500076-00006. [DOI] [PubMed] [Google Scholar]
  24. Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983 Jun 9;303(5917):535–537. doi: 10.1038/303535a0. [DOI] [PubMed] [Google Scholar]
  25. Schramm M., Towart R., Lamp B., Thomas G. Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY K 8644. J Cardiovasc Pharmacol. 1985 May-Jun;7(3):493–496. doi: 10.1097/00005344-198505000-00012. [DOI] [PubMed] [Google Scholar]
  26. Schramm M., Towart R. Modulation of calcium channel function by drugs. Life Sci. 1985 Nov 18;37(20):1843–1860. doi: 10.1016/0024-3205(85)90001-3. [DOI] [PubMed] [Google Scholar]
  27. Schwartz A., Triggle D. J. Cellular action of calcium channel blocking drugs. Annu Rev Med. 1984;35:325–339. doi: 10.1146/annurev.me.35.020184.001545. [DOI] [PubMed] [Google Scholar]
  28. Silinsky E. M. The biophysical pharmacology of calcium-dependent acetylcholine secretion. Pharmacol Rev. 1985 Mar;37(1):81–132. [PubMed] [Google Scholar]
  29. Stanfield P. R. Voltage-dependent calcium channels of excitable membranes. Br Med Bull. 1986 Oct;42(4):359–367. doi: 10.1093/oxfordjournals.bmb.a072153. [DOI] [PubMed] [Google Scholar]
  30. Thomas G., Chung M., Cohen C. J. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ Res. 1985 Jan;56(1):87–96. doi: 10.1161/01.res.56.1.87. [DOI] [PubMed] [Google Scholar]
  31. Tucek S., Dolezal V., Folbergrová J., Hynie S., Kolár F., Ostádal B. Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart. Pflugers Arch. 1987 Feb;408(2):167–172. doi: 10.1007/BF00581347. [DOI] [PubMed] [Google Scholar]
  32. Wei J. W., Chiang D. H. Studies of [3H]nitrendipine binding and KCl-induced calcium uptake in rat cortical synaptosomes. Gen Pharmacol. 1985;16(3):211–216. doi: 10.1016/0306-3623(85)90071-0. [DOI] [PubMed] [Google Scholar]
  33. Woodward J. J., Leslie S. W. Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine. Brain Res. 1986 Apr 9;370(2):397–400. doi: 10.1016/0006-8993(86)90502-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES